HR001 was identified to obtain an efficacious reaction for patients with relapsed/refractory non-Hodgkin lymphoma. Numerous pharmacological inhibitors of the mtCU are divalent/trivalent cations or polycations. Divalents/trivalents can both traverse mtCU and work as competitive inhibitors of Ca2+ like Sr2+ or bind on the channel with out permeation like Mg2+ or https://heinzu000iuf3.azuria-wiki.com/user